AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
about
Therapeutic potential of the renin angiotensin system in ischaemic strokeDirect angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive ratsCandesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B.Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function.Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesisAngiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathwaysSequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.Neurorestoration after traumatic brain injury through angiotensin II receptor blockageCellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period.Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental strokePronerve growth factor induces angiogenesis via activation of TrkA: possible role in proliferative diabetic retinopathy.Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.In Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T.Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonism.Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in ratsARBs improve stroke outcome through an AT2-dependent, BDNF-induced proangiogenic and prorecovery response.Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1).Vascular protective effects of Angiotensin Receptor Blockers: Beyond Blood pressure.Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3β Inhibition-Induced Reduction of VEGF Release.Effects of senescence and angiotensin II on expression and processing of amyloid precursor protein in human cerebral microvascular endothelial cells.Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals - A randomized double- blind pre-clinical study.Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.Within the Brain: The Renin Angiotensin System.
P2860
Q28077553-1B74E2AD-DC87-47CF-AAA0-61620CC42F72Q28538103-EAD2DFD6-E0CE-4E9F-892B-74760A014BEDQ33603639-D609F097-2D42-41AB-898B-10EF799030F4Q33914333-2051909F-B9B8-44C0-B70B-7FC121F51EB4Q34125083-C219CD68-E71C-41AB-85B7-ED2C9A41847DQ35875449-0BD8B7CD-6381-4322-AF74-2633D4A69D88Q36026755-AB481181-0279-4A57-8A4D-17F72A43C2B8Q36412546-F99EEF5C-7976-4E45-8046-52CBF862B91AQ36515931-E4049E40-39B0-4705-B818-91F877DB07F6Q36551157-4C2D666A-8D3F-45FA-B4DF-D4BC7BF45D46Q36846675-3A71375B-F606-42FE-86D8-76CFE033D659Q37122419-6DD966C6-2EF4-4A5A-8680-C15716A22261Q38592712-18BCC45B-DE6A-4FFD-89A7-2FAEA7AFC068Q40095437-05D2C4BF-4CB4-4873-B0A6-7EBFAF003205Q41668994-30205A1B-6E2A-4178-A03B-B8171F184C9CQ41967249-16772FE1-1BDD-4A33-85A9-7FFEC3ABFB4CQ42249268-F836813A-427A-48D7-BA24-CFA16CBE8532Q42400651-415C3605-352A-46BE-9F71-ED3905F46752Q42739089-58E09279-AAA4-4AAE-B763-628170D34D7AQ42837025-910DDC4C-1349-4649-965A-655AD7669285Q47133435-3B377DE4-4679-49CC-BFD3-2EA0927CD8BEQ47853250-271B6CA4-4C0A-495D-BD9C-928FCCE53835Q47921304-73E0B485-B094-40FB-B523-188982351BD8Q48643095-830CB4C5-25E3-4A2B-876D-73A6F13F2EC4Q49011342-CE9C49D7-3675-4442-A436-7E47A53AE500Q51762826-CF646728-7549-4284-8F6C-3CD46AFBF0DB
P2860
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
@ast
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
@en
type
label
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
@ast
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
@en
prefLabel
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
@ast
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
@en
P2093
P2860
P356
P1476
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator
@en
P2093
Adviye Ergul
Anna Kozak
Susan C Fagan
P2860
P304
P356
10.1124/JPET.112.197483
P407
P577
2012-12-04T00:00:00Z